News Chart Neurogene Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/02/2026 GMT			5-day change	1st Jan Change
17.00 ^USD	-3.52%		-3.19%	-17.48%

02-04	Neurogene announces inducement grant under Nasdaq Listing Rule	RE
01-12	Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-In-Class Gene Therapy for Rett Syndrome	CI

c.wGPeYePTjah9ICLb2nzlT9LIQ-J3UhlIBtYY-dcRZgM.hCSkL5KMx9k_SFTsjBCqEL_-MZtaGCB7VrQrquJDXmuLL50Gs7_HyzZuEg~e3248ae36ca43679034f22594eb9c3a1